Home > Insider Trading > Filing (0001237899-21-000022)

Filing Details

Accession Number:: 0001237899-21-000022
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-17 16:01:13
Reporting Period:: 2021-09-15

Accepted Time:: 2021-09-17 16:01:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197018	Anthony N Coles	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-15	6,909	$380.95	7,811	No	4	M	Direct
Common Stock	Acquisiton	2021-09-15	5,039	$345.47	12,850	No	4	M	Direct
Common Stock	Disposition	2021-09-15	300	$651.36	12,550	No	4	S	Direct
Common Stock	Disposition	2021-09-15	1,101	$652.95	11,449	No	4	S	Direct
Common Stock	Disposition	2021-09-15	800	$653.31	10,649	No	4	S	Direct
Common Stock	Disposition	2021-09-15	403	$655.14	10,246	No	4	S	Direct
Common Stock	Disposition	2021-09-15	1,400	$656.48	8,846	No	4	S	Direct
Common Stock	Disposition	2021-09-15	835	$657.53	8,011	No	4	S	Direct
Common Stock	Disposition	2021-09-15	935	$658.65	7,076	No	4	S	Direct
Common Stock	Disposition	2021-09-15	300	$659.00	6,776	No	4	S	Direct
Common Stock	Disposition	2021-09-15	448	$660.78	6,328	No	4	S	Direct
Common Stock	Disposition	2021-09-15	3,344	$661.56	2,984	No	4	S	Direct
Common Stock	Disposition	2021-09-15	3	$662.55	2,981	No	4	S	Direct
Common Stock	Disposition	2021-09-15	905	$663.73	2,076	No	4	S	Direct
Common Stock	Disposition	2021-09-15	1,174	$664.32	902	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-09-15	5,039	$0.00	5,039	$345.47
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-09-15	6,909	$0.00	6,909	$380.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-01-27	No	4	M	Direct
0		2028-01-02	No	4	M	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 15, 2021 at prices ranging from $652.48 to $652.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 800 shares of Company stock on September 15, 2021 at prices ranging from $653.11 to $653.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 403 shares of Company stock on September 15, 2021 at prices ranging from $655.14 to $655.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,400 shares of Company stock on September 15, 2021 at prices ranging from $656.18 to $656.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 448 shares of Company stock on September 15, 2021 at prices ranging from $660.29 to $660.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,344 shares of Company stock on September 15, 2021 at prices ranging from $661.02 to $661.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 905 shares of Company stock on September 15, 2021 at prices ranging from $663.15 to $663.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,174 shares of Company stock on September 15, 2021 at prices ranging from $664.00 to $664.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.